Discharge Planning Program for Post CABG Patients
Launched by UNIVERSITY OF JORDAN · Aug 22, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Cardiovascular diseases (CVD) are the main threats to human lives (Benjamin et al., 2018). Around 17.9 million deaths worldwide were attributed to CVD (Benjamin et al., 2018); Which Represents 31 % of the global deaths (Benjamin et al., 2018). Coronary artery disease is one of the CVD. Coronary artery disease prevalence among United State (US) adults aged 20 years and above is 6.3 %. It is responsible for 43.8 % of the deaths worldwide. (Benjamin et al., 2018).
In Jordan, CVD is the leading cause of death. During 2016; 37 % of all deaths among Jordanian population were due to CVD. Coronary...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient aged 21 years or older
- • Underwent first time isolated elective CABG surgery for single, double, or triple CAD.
- • Patient speak and read Arabic to eliminate any barriers of communication during the process of discharge and telephone call
- • Patient who has contact telephone number
- • Doesn't have Aortic calcification, and /or previous stroke
- • Welling to participate and Able to provide informed consent
- Exclusion Criteria:
- • Adult patient aged 21 years or older
- • Underwent first time isolated elective CABG surgery for single, double, or triple CAD.
- • Patient speak and read Arabic to eliminate any barriers of communication during the process of discharge and telephone call
- • Patient who has contact telephone number
- • Doesn't have Aortic calcification, and /or previous stroke
- • Welling to participate and Able to provide informed consent
About University Of Jordan
The University of Jordan, a leading institution in higher education and research in the region, is dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to ethical research practices and collaboration with various stakeholders, the University of Jordan aims to contribute significantly to the field of medicine by exploring new treatments and interventions. Its robust infrastructure and expertise in diverse health-related disciplines enable the university to conduct high-quality studies that address pressing health challenges, ultimately enhancing patient care and fostering scientific discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amman, , Jordan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials